Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...

Small-caps often see upward moves around the presidential election. A Trump win would boost the sector even further, Cantor ...

Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...

Inc. (NASDAQ:ETNB – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven ratings firms that ...

In a report released yesterday, Sarah James from Cantor Fitzgerald maintained a Buy rating on UnitedHealth (UNH – Research Report), with ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...

NEW YORK, Oct. 15, 2024 /PRNewswire/ -- Cantor Fitzgerald Infrastructure Fund (the "Fund") today announced a third-quarter distribution of $0.1170 per Class A share (NASDAQ: CAFIX), $0.1156 per ...

On Tuesday, Cantor Fitzgerald began covering LeMaitre Vascular (NASDAQ:LMAT), a company specializing in medical devices and services for peripheral vascular disease treatment, with a Neutral ...

NEW YORK, Oct. 15, 2024 /PRNewswire/ -- Cantor Fitzgerald Infrastructure Fund (the "Fund") today announced a third-quarter distribution of $0.1170 per Class A share (NASDAQ: CAFIX), $0.1156 per Class ...

Cantor Fitzgerald has initiated coverage on Ideaya Biosciences (NASDAQ: IDYA) with an Overweight rating. The firm's analysis suggests significant potential for the company's leading drug ...